Prophylactic cranial irradiation (PCI) in locally advanced non-small cell lung cancer: time for hope?
Prophylactic cranial irradiation (PCI) in locally advanced non-small cell lung cancer: time for hope? |
|
https://doi.org/10.18632/oncotarget.25866
Dirk K. De Ruysscher,
and Harry J. Groen
|
| 32274-32275 |
Disabling an oncogenic transcription factor by targeting of control kinases
Disabling an oncogenic transcription factor by targeting of control kinases |
|
https://doi.org/10.18632/oncotarget.25971
Christopher R. Vakoc,
and Alex Kentsis
|
| 32276-32277 |
A metabolic vulnerability of small-cell lung cancer
A metabolic vulnerability of small-cell lung cancer |
|
https://doi.org/10.18632/oncotarget.25964
Miyuki Nomura,
Mami Morita,
and Nobuhiro Tanuma
|
| 32278-32279 |
xCT inhibition sensitizes tumors to γ-radiation via glutathione reduction
xCT inhibition sensitizes tumors to γ-radiation via glutathione reduction |
|
https://doi.org/10.18632/oncotarget.25794
Lara Cobler,
Hui Zhang,
Poojan Suri,
Catherine Park,
and Luika A. Timmerman
|
| 32280-32297 |
Immune checkpoint inhibitor re-challenge in patients with advanced non-small cell lung cancer
Immune checkpoint inhibitor re-challenge in patients with advanced non-small cell lung cancer |
|
https://doi.org/10.18632/oncotarget.25949
Maiko Niki,
Aya Nakaya,
Takayasu Kurata,
Hiroshige Yoshioka,
Toshihiko Kaneda,
Kayoko Kibata,
Makoto Ogata,
and Shosaku Nomura
|
| 32298-32304 |
Terpenes from essential oils and hydrolate of Teucrium alopecurus triggered apoptotic events dependent on caspases activation and PARP cleavage in human colon cancer cells through decreased protein expressions
Terpenes from essential oils and hydrolate of Teucrium alopecurus triggered apoptotic events dependent on caspases activation and PARP cleavage in human colon cancer cells through decreased protein expressions |
|
https://doi.org/10.18632/oncotarget.25955
Fatma Guesmi,
Amit K. Tyagi,
Sahdeo Prasad,
and Ahmed Landoulsi
|
| 32305-32320 |
Race and nodal disease status are prognostic factors in patients with stage IVB cervical cancer
Race and nodal disease status are prognostic factors in patients with stage IVB cervical cancer |
|
https://doi.org/10.18632/oncotarget.25962
Shin Nishio,
Koji Matsuo,
Koji Yonemoto,
Mototsugu Shimokawa,
Masayuki Hosaka,
Michiko Kodama,
Takahito M. Miyake,
Kimio Ushijima,
Toshiharu Kamura,
Shannon N. Westin,
Pamela T. Soliman,
and Robert L. Coleman
|
| 32321-32330 |
Snail mediates repression of the Dlk1-Dio3 locus in lung tumor-infiltrating immune cells
Snail mediates repression of the Dlk1-Dio3 locus in lung tumor-infiltrating immune cells |
|
https://doi.org/10.18632/oncotarget.25965
Svenja Groeneveld,
Julien Faget,
Nadine Zangger,
and Etienne Meylan
|
| 32331-32345 |
Online structure-based screening of purchasable approved drugs and natural compounds: retrospective examples of drug repositioning on cancer targets
Online structure-based screening of purchasable approved drugs and natural compounds: retrospective examples of drug repositioning on cancer targets |
|
https://doi.org/10.18632/oncotarget.25966
Nathalie Lagarde,
Julien Rey,
Aram Gyulkhandanyan,
Pierre Tufféry,
Maria A. Miteva,
and Bruno O. Villoutreix
|
| 32346-32361 |
RNA based individualized drug selection in breast cancer patients without patient-matched normal tissue
RNA based individualized drug selection in breast cancer patients without patient-matched normal tissue |
|
https://doi.org/10.18632/oncotarget.25981
Michael Forster,
Adam Mark,
Friederike Egberts,
Elisa Rosati,
Elke Rodriguez,
Martin Stanulla,
Dirk Bauerschlag,
Christian Schem,
Nicolai Maass,
Anu Amallraja,
Karla K. Murphy,
Bruce R. Prouse,
Raed A. Sulaiman,
Brandon M. Young,
Micaela Mathiak,
Georg Hemmrich-Stanisak,
David Ellinghaus,
Stephan Weidinger,
Philip Rosenstiel,
Norbert Arnold,
Brian Leyland-Jones,
Casey B. Williams,
Andre Franke,
and Tobias Meißner
|
| 32362-32372 |
Association between red and processed meat intake and colorectal adenoma incidence and recurrence: a systematic review and meta-analysis
Association between red and processed meat intake and colorectal adenoma incidence and recurrence: a systematic review and meta-analysis |
|
https://doi.org/10.18632/oncotarget.23561
Zhanwei Zhao,
Zifang Yin,
Zhenning Hang,
Chaojun Zhang,
and Qingchuan Zhao
|
| 32373-32382 |
Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma
Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma |
|
https://doi.org/10.18632/oncotarget.25892
Eva González-Barca,
Mónica Coronado,
Alejandro Martín,
Carlos Montalbán,
Santiago Montes-Moreno,
Carlos Panizo,
Guillermo Rodríguez,
Juan Manuel Sancho,
Andrés López-Hernández,
and on behalf of the Spanish Lymphoma Group (GELTAMO)
|
| 32383-32399 |
Erratum: Will PI3K pathway inhibitors be effective as single agents in patients with cancer?
Erratum: Will PI3K pathway inhibitors be effective as single agents in patients with cancer? |
|
https://doi.org/10.18632/oncotarget.26017
Joan T. Garrett,
Anindita Chakrabarty,
and Carlos L. Arteaga
|
| 32400-32400 |
Correction: Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cells
Correction: Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cells |
|
https://doi.org/10.18632/oncotarget.26018
Christian Schütz,
Juan Carlos Varela,
Karlo Perica,
Carl Haupt,
Mathias Oelke,
and Jonathan P. Schneck
|
| 32401-32401 |
Correction: Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: identification of functional disparities between azacytidine and decitabine
Correction: Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: identification of functional disparities between azacytidine and decitabine |
|
https://doi.org/10.18632/oncotarget.26019
Yao-Yu Hsieh,
Tsui-Chin Huang,
Hsiang-Ling Lo,
Jyun-Yan Jhan,
Shui-Tein Chen,
and Pei-Ming Yang
|
| 32402-32402 |
Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance
Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance |
|
https://doi.org/10.18632/oncotarget.26020
Man Kit Siu,
Wassim Abou-Kheir,
Juan Juan Yin,
Yung-Sheng Chang,
Ben Barrett,
Florent Suau,
Orla Casey,
Wei-Yu Chen,
Lei Fang,
Paul Hynes,
Yao-Yu Hsieh,
Yen-Nien Liu,
Jiaoti Huang,
and Kathleen Kelly
|
| 32403-32403 |
